36. 表皮水疱症 Epidermolysis bullosa Clinical trials / Disease details

臨床試験数 : 163 / 薬物数 : 185 - (DrugBank : 46) / 標的遺伝子数 : 50 - 標的パスウェイ数 : 125

3 trials found

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05651607 (ClinicalTrials.gov)	January 2023	7/12/2022	Evaluation of the Efficacy of CANNABIDIOLon the Pruritus in Children With Hereditary Epidermolysis B ...	Evaluation of the Efficacy of CANNABIDIOLon the Pruritus in Children With Hereditary Epidermolysis B ...	Hereditary Epidermolysis Bullosa	Drug: Cannabidiol	Assistance Publique - Hôpitaux de Paris	HELEBOR;Fondation Apicil;Lions Club International Foundation	Not yet recruiting	2 Years	17 Years	All	10	Phase 2	France
2	NCT04613102 (ClinicalTrials.gov)	August 1, 2020	27/10/2020	The Efficacy and Safety of 3% Cannabidiol(CBD) Cream in Patients With Epidermolysis Bullosa: A Phase ...	The Efficacy and Safety of 3% Cannabidiol(CBD) Cream in Patients With Epidermolysis Bullosa: A Phase ...	Epidermolysis Bullosa;Pain;Itch	Drug: AVCN583601 (3% Cannabidiol cream)	Elena Pope	Avicanna Inc	Withdrawn	4 Years	50 Years	All	0	Phase 2/Phase 3	Canada
3	EUCTR2021-000103-20-NL (EUCTR)		15/07/2021	A study on the effect of Transvamix on pain in adults with epidermolysis bullosa.	An explorative randomized, placebo-controlled and double-blind intervention crossover study: Transva ...	Genetic Epidermolysis Bullosa;Therapeutic area: Diseases [C] - Symptoms and general pathology [C23]	Product Name: Transvamix (100mg/mL THC, 50mg/mL CBD) INN or Proposed INN: THC Other descriptive name: ...	University Medical Center Groningen	NULL	NA			Female: yes Male: yes	16	Phase 2	Netherlands

First Previous1Next Last